Our results reveal a EZH2-SOX9-TNFRSF11A axis in the regulation of NF-κB signaling in PCa cells, suggesting that targeting this axis could provide therapeutic promise. This evidence concerns the gene TNFRSF11A and posterior cortical atrophy.